Roth Mkm Lowers Aspen Aerogels (NYSE:ASPN) Price Target to $16.00

Aspen Aerogels (NYSE:ASPN) had its target price reduced by equities research analysts at Roth Mkm from $22.00 to $16.00 in a note issued to investors on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the construction company’s stock. Roth Mkm’s target price would suggest a potential upside of 84.63% from the company’s previous close.

Several other equities research analysts have also issued reports on the stock. Barclays lowered their price target on shares of Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 12th. Craig Hallum lowered their price target on shares of Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating on the stock in a research note on Friday. Piper Sandler lowered their price target on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 22nd. Canaccord Genuity Group lowered their price target on shares of Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating on the stock in a research note on Friday. Finally, StockNews.com upgraded shares of Aspen Aerogels to a “sell” rating in a research note on Saturday, February 8th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $24.67.

Aspen Aerogels Trading Down 3.7 %

ASPN opened at $8.67 on Friday. The stock has a market capitalization of $711.05 million, a P/E ratio of 867.47 and a beta of 2.14. Aspen Aerogels has a 12 month low of $8.25 and a 12 month high of $33.15. The firm’s fifty day simple moving average is $12.17 and its 200 day simple moving average is $18.46. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings data on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, beating the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a net margin of 0.36% and a return on equity of 5.06%. As a group, research analysts anticipate that Aspen Aerogels will post 0.12 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of ASPN. SG Americas Securities LLC acquired a new position in Aspen Aerogels in the 3rd quarter valued at about $379,000. nVerses Capital LLC grew its stake in Aspen Aerogels by 45.0% in the 3rd quarter. nVerses Capital LLC now owns 5,800 shares of the construction company’s stock valued at $161,000 after buying an additional 1,800 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its holdings in Aspen Aerogels by 415.2% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 238,884 shares of the construction company’s stock valued at $6,615,000 after purchasing an additional 192,520 shares during the period. Precision Wealth Strategies LLC bought a new stake in Aspen Aerogels in the 3rd quarter valued at about $348,000. Finally, Dakota Wealth Management bought a new stake in Aspen Aerogels in the 3rd quarter valued at about $986,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.